SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Proterra Inc. (PTRA) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+10347.8%).
- Analyst consensus target $7.00 (+10347.8% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 41/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PTRA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.05
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.02
Book Value / Share$0.00
Revenue / Share$1.24
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$7.00 (+10347.8%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.51 |
$181.28M |
$-106.52M |
-58.8% |
| 2020 |
$-0.61 |
$196.94M |
$-127.01M |
-64.5% |
| 2021 |
$-1.13 |
$242.86M |
$-250.01M |
-102.9% |
| 2022 |
$-1.02 |
$309.36M |
$-255.05M |
-82.4% |
